Design and Optimization of Controlled Release Ketoprofen Tablets

被引：0
|
作者：
Zafar, Farya [1 ]
Shoaib, Muhammad H. [1 ]
Ali, Huma [2 ]
Alam, Zafar M. [1 ]
机构：
[1] Univ Karachi, Fac Pharm, Dept Pharmaceut, Karachi, Pakistan
[2] Ziauddin Univ, Fac Pharm, Karachi, Pakistan
来源：
LATIN AMERICAN JOURNAL OF PHARMACY | 2015年 / 34卷 / 03期
关键词：
Controlled release; Direct compression; Ketoprofen; Optimization; MATRIX TABLETS; DRUG-RELEASE; SODIUM; THEOPHYLLINE; DISSOLUTION;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
The aim of this study is to develop and optimize controlled release ketoprofen formulations using central composite design (CCRD) (Design Expert software, version 7.0.0). Fifteen different formulations (F1-F15) were designed by response surface methodology with CCRD. All the formulations are compressed by direct compression method. Microcrystalline cellulose (Avicel PH-102) (30-45%), methocel K4M (15-25%) and magnesium stearate (1-2%) were selected as independent variables while % friability, % drug release, and Carr's index were chosen as a response variables. Different physico-chemical tests were performed. Results were found to be in adequate limits. It was found that central composite design can be used as cost effective tool for optimization and development of controlled release formulations.
引用
收藏
页码：429 / 436
页数：8
相关论文
共 50 条
  • [31] Design, Development, and Evaluation of Controlled Release Tablets of Nateglinide Solid Dispersions
    Sunitha, Ramisetty
    Venugopal, K.
    Satyanarayana, S., V
    ASIAN JOURNAL OF PHARMACEUTICS, 2021, 15 (01) : 115 - 123
  • [32] Formulation, development, and optimization of immediate release nateglinide tablets by factorial design
    Pani, Nihar R.
    Nath, Lila K.
    Bhunia, Biswanath
    DRUG DISCOVERIES AND THERAPEUTICS, 2010, 4 (06): : 453 - 458
  • [33] Optimization of LY545694 Tosylate Controlled Release Tablets Through Pharmacoscintigraphy
    Lobo, Evelyn D.
    Argentine, Mark D.
    Sperry, David C.
    Connor, Alyson
    McDermott, John
    Stevens, Lloyd
    Almaya, Ahmad
    PHARMACEUTICAL RESEARCH, 2012, 29 (10) : 2912 - 2925
  • [34] Optimization of LY545694 Tosylate Controlled Release Tablets Through Pharmacoscintigraphy
    Evelyn D. Lobo
    Mark D. Argentine
    David C. Sperry
    Alyson Connor
    John McDermott
    Lloyd Stevens
    Ahmad Almaya
    Pharmaceutical Research, 2012, 29 : 2912 - 2925
  • [35] Formulation and optimization of osmotically controlled release tablets of glipizide: hot melt granulation
    Panda, Rashmi R.
    Tiwary, Ashok K.
    THERAPEUTIC DELIVERY, 2010, 1 (06) : 763 - 774
  • [36] EVALUATION OF IBUPROFEN CONTROLLED RELEASE TABLETS .1. EUDRAGIT(R) MATRIX CONTROLLED RELEASE TABLETS
    RAHMAN, AAA
    SAMY, EM
    RAHMAN, SIA
    ABOUTALEB, AE
    STAMM, A
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 1992, 38 (02) : 71 - 77
  • [37] Controlled release tablets of verapamil hydrochloride
    Treephu Kimlek
    Tossaporn Prasertporn
    Jiramet Sawantranon
    Chaisan Sriwichupong
    Garnpimol Ritthidej
    AsianJournalofPharmaceuticalSciences, 2016, 11 (01) : 219 - 220
  • [38] CONTROLLED-RELEASE MORPHINE TABLETS
    HANKS, GW
    ROSE, NM
    AHERNE, GW
    PIALL, EM
    FAIRFIELD, S
    TRUEMAN, T
    BRITISH JOURNAL OF ANAESTHESIA, 1981, 53 (12) : 1259 - 1264
  • [39] Mucoadhesive Tablets for Controlled Release of Acyclovir
    Ruiz-Caro, Roberto
    Gago-Guillan, Manuel
    Javier Otero-Espinar, Francisco
    Dolores Veiga, Maria
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2012, 60 (10) : 1249 - 1257
  • [40] Influence of cellulose ether polymers on ketoprofen release from hydrophilic matrix tablets
    Vueba, ML
    Batista De Carvalho, LAE
    Veiga, F
    Sousa, JJ
    Pina, ME
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2004, 58 (01) : 51 - 59
12345